Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
Clinical trial NCT05391750 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05391750
- Sponsor
- Emory University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-19
- Primary completion
- 2027-02-12
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.